Role of very low dose statin therapy in PCSK9 inib. treated patients
Anno:
2024
Female patient 62 years old Cardiovascular risk factors: Arterial hypertension, smoking, obesity, dyslipidemia, hypercholesterolemia, family history of cardiovascular diseases (father who died from miocardial infarction (MI) and brother with 3 MI). Intolerance to various statins (myalgia) Non-critical atherosclerosis of the supra-aortic trunks. Therapy with PCSK9 inib. started. (evolocumab 140…